• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

敲低 PPAR δ 基因促进结肠癌在裸鼠模型中的生长并降低对贝伐珠单抗的敏感性。

Knockdown of PPAR δ gene promotes the growth of colon cancer and reduces the sensitivity to bevacizumab in nude mice model.

机构信息

Institute of Digestive Surgery and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.

出版信息

PLoS One. 2013 Apr 8;8(4):e60715. doi: 10.1371/journal.pone.0060715. Print 2013.

DOI:10.1371/journal.pone.0060715
PMID:23593291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3620168/
Abstract

The role of peroxisome proliferator--activated receptor- δ (PPAR δ) gene in colon carcinogenesis remains highly controversial. Here, we established nude mice xenograft model using a human colon cancer cell line KM12C either with PPAR δ silenced or normal. The xenografts in PPAR δ-silenced group grew significantly larger and heavier with less differentiation, promoted cell proliferation, increased expression of vascular endothelial growth factor (VEGF) and similar apoptosis index compared with those of PPAR δ-normal group. After treated with the specific VEGF inhibitor bevacizumab, the capacities of growth and proliferation of xenografts were decreased in both groups while still significantly higher in PPAR δ-silenced group than in PPAR δ-normal group. Administration of PPAR δ agonist significantly decreased VEGF expression in PPAR δ-normal KM12C cells but not in PPAR δ-silenced cells. These findings demonstrate that, knockdown of PPAR δ promotes the growth of colon cancer by inducing less differentiation, accelerating the proliferation and VEGF expression of tumor cells in vivo, and reduces tumor sensitivity to bevacizumab. This study indicates that PPAR δ attenuates colon carcinogenesis.

摘要

过氧化物酶体增殖物激活受体-δ(PPAR δ)基因在结肠癌发生中的作用仍存在很大争议。在这里,我们建立了裸鼠异种移植模型,使用沉默或正常的人结肠癌细胞系 KM12C。与 PPAR δ-正常组相比,PPAR δ 沉默组的异种移植物生长显著增大且重量增加,分化减少,促进细胞增殖,血管内皮生长因子(VEGF)表达增加,凋亡指数相似。用特异性 VEGF 抑制剂贝伐单抗处理后,两组的生长和增殖能力均下降,但 PPAR δ-沉默组仍明显高于 PPAR δ-正常组。PPAR δ 激动剂显著降低了 PPAR δ-正常 KM12C 细胞中 VEGF 的表达,但对 PPAR δ 沉默细胞没有作用。这些发现表明,敲低 PPAR δ 通过诱导分化减少、加速体内肿瘤细胞的增殖和 VEGF 表达来促进结肠癌的生长,并降低肿瘤对贝伐单抗的敏感性。本研究表明 PPAR δ 可抑制结肠癌的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088a/3620168/600d1cc2d54d/pone.0060715.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088a/3620168/5dd8612d9224/pone.0060715.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088a/3620168/d4e06d3c0b9d/pone.0060715.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088a/3620168/dfe239a8fd6b/pone.0060715.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088a/3620168/f96181253ae1/pone.0060715.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088a/3620168/7809b6e2bc03/pone.0060715.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088a/3620168/600d1cc2d54d/pone.0060715.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088a/3620168/5dd8612d9224/pone.0060715.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088a/3620168/d4e06d3c0b9d/pone.0060715.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088a/3620168/dfe239a8fd6b/pone.0060715.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088a/3620168/f96181253ae1/pone.0060715.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088a/3620168/7809b6e2bc03/pone.0060715.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088a/3620168/600d1cc2d54d/pone.0060715.g006.jpg

相似文献

1
Knockdown of PPAR δ gene promotes the growth of colon cancer and reduces the sensitivity to bevacizumab in nude mice model.敲低 PPAR δ 基因促进结肠癌在裸鼠模型中的生长并降低对贝伐珠单抗的敏感性。
PLoS One. 2013 Apr 8;8(4):e60715. doi: 10.1371/journal.pone.0060715. Print 2013.
2
Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts.抗血管内皮生长因子抗体治疗诱导肿瘤缺氧和促甲状腺素释放激素 2 表达,并增强人结肠癌细胞异种移植物的生长。
Int J Cancer. 2014 Jul 15;135(2):295-307. doi: 10.1002/ijc.28686. Epub 2014 Jan 6.
3
PPAR-gamma ligand promotes the growth of APC-mutated HT-29 human colon cancer cells in vitro and in vivo.过氧化物酶体增殖物激活受体γ配体在体外和体内均可促进APC基因发生突变的HT-29人结肠癌细胞的生长。
Invest New Drugs. 2008 Jun;26(3):283-8. doi: 10.1007/s10637-007-9108-x. Epub 2007 Dec 27.
4
Knockdown of peroxisome proliferator-activated receptor-beta induces less differentiation and enhances cell-fibronectin adhesion of colon cancer cells.过氧化物酶体增殖物激活受体-β的敲低可诱导结肠癌细胞分化减少,并增强细胞与纤维连接蛋白的黏附。
Oncogene. 2010 Jan 28;29(4):516-26. doi: 10.1038/onc.2009.370. Epub 2009 Nov 23.
5
[Impacts of Bevacizumab on vascular endothelial growth factor and Sp1 expression in gastric cancer xenografts].[贝伐单抗对胃癌异种移植瘤中血管内皮生长因子及Sp1表达的影响]
Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Feb;15(2):180-4.
6
Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis.过氧化物酶体增殖物激活受体δ的靶向基因破坏与结肠肿瘤发生
J Natl Cancer Inst. 2009 May 20;101(10):762-7. doi: 10.1093/jnci/djp078. Epub 2009 May 12.
7
Targeting the insulin growth factor and the vascular endothelial growth factor pathways in ovarian cancer.靶向卵巢癌中的胰岛素生长因子和血管内皮生长因子通路。
Mol Cancer Ther. 2012 Jul;11(7):1576-86. doi: 10.1158/1535-7163.MCT-11-0961. Epub 2012 Jun 13.
8
Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter.脂肪酸激活的PPARγ通过启动子的PPAR反应元件上调VEGF,从而促进前列腺癌细胞的致瘤性。
Oncotarget. 2016 Feb 23;7(8):9322-39. doi: 10.18632/oncotarget.6975.
9
Detection of vascular endothelial growth factor in colon cancer xenografts using bevacizumab based near infrared fluorophore conjugate.使用基于贝伐单抗的近红外荧光团缀合物检测结肠癌异种移植瘤中的血管内皮生长因子
J Biomed Sci. 2014 Apr 29;21(1):35. doi: 10.1186/1423-0127-21-35.
10
Modulation of transcription by the peroxisome proliferator-activated receptor delta--binding RNA aptamer in colon cancer cells.过氧化物酶体增殖物激活受体 δ 结合 RNA 适体对结肠癌细胞转录的调节作用。
Mol Cancer Ther. 2009 Sep;8(9):2664-73. doi: 10.1158/1535-7163.MCT-09-0214. Epub 2009 Sep 1.

引用本文的文献

1
NKD1 enhances colon cancer progression by inhibiting the autophagic degradation of MYC.NKD1通过抑制MYC的自噬降解来促进结肠癌进展。
Cell Death Dis. 2025 Jul 17;16(1):532. doi: 10.1038/s41419-025-07875-8.
2
Identification and analysis of prognostic metabolic characteristics in colon adenocarcinoma.结肠腺癌预后代谢特征的鉴定与分析
Heliyon. 2024 Mar 5;10(6):e27388. doi: 10.1016/j.heliyon.2024.e27388. eCollection 2024 Mar 30.
3
Delineating the role of nuclear receptors in colorectal cancer, a focused review.阐述核受体在结直肠癌中的作用:一篇重点综述

本文引用的文献

1
Biological function and prognostic significance of peroxisome proliferator-activated receptor δ in rectal cancer.过氧化物酶体增殖物激活受体 δ 在直肠癌中的生物学功能和预后意义。
Clin Cancer Res. 2011 Jun 1;17(11):3760-70. doi: 10.1158/1078-0432.CCR-10-2779. Epub 2011 Apr 29.
2
Metabolic and nonmetabolic regulatory functions of peroxisome proliferator-activated receptor beta.过氧化物酶体增殖物激活受体 β 的代谢和非代谢调节功能。
Curr Opin Lipidol. 2010 Jun;21(3):186-91. doi: 10.1097/mol.0b013e32833884a4.
3
Knockdown of peroxisome proliferator-activated receptor-beta induces less differentiation and enhances cell-fibronectin adhesion of colon cancer cells.
Discov Oncol. 2024 Feb 19;15(1):41. doi: 10.1007/s12672-023-00808-x.
4
High expression of cytoplasmic FOXO3 protein associated with poor prognosis of rectal cancer patients: A study from Swedish clinical trial of preoperative radiotherapy to big database analysis.细胞质FOXO3蛋白高表达与直肠癌患者预后不良相关:一项从瑞典术前放疗临床试验到大型数据库分析的研究
Heliyon. 2023 Apr 10;9(5):e15342. doi: 10.1016/j.heliyon.2023.e15342. eCollection 2023 May.
5
Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.过氧化物酶体增殖物激活受体与癌症的特征。
Cells. 2022 Aug 5;11(15):2432. doi: 10.3390/cells11152432.
6
The Expression of PPAR Pathway-Related Genes Can Better Predict the Prognosis of Patients with Colon Adenocarcinoma.PPAR通路相关基因的表达能更好地预测结肠腺癌患者的预后。
PPAR Res. 2022 Apr 18;2022:1285083. doi: 10.1155/2022/1285083. eCollection 2022.
7
Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway.配体激活的 PPARδ 表达通过调节 PI3K-AKT 信号通路促进肝癌进展。
J Transl Med. 2022 Feb 12;20(1):86. doi: 10.1186/s12967-022-03288-9.
8
Knockdown of PPARδ Induces VEGFA-Mediated Angiogenesis Interaction With ERO1A in Human Colorectal Cancer.敲低PPARδ可诱导人结直肠癌中VEGFA介导的血管生成并与ERO1A相互作用。
Front Oncol. 2021 Oct 12;11:713892. doi: 10.3389/fonc.2021.713892. eCollection 2021.
9
PPARs and Tumor Microenvironment: The Emerging Roles of the Metabolic Master Regulators in Tumor Stromal-Epithelial Crosstalk and Carcinogenesis.过氧化物酶体增殖物激活受体与肿瘤微环境:代谢主调控因子在肿瘤基质-上皮细胞相互作用及致癌过程中的新作用
Cancers (Basel). 2021 Apr 29;13(9):2153. doi: 10.3390/cancers13092153.
10
PPAR Beta/Delta and the Hallmarks of Cancer.过氧化物酶体增殖物激活受体-β/δ 与癌症的特征。
Cells. 2020 May 4;9(5):1133. doi: 10.3390/cells9051133.
过氧化物酶体增殖物激活受体-β的敲低可诱导结肠癌细胞分化减少,并增强细胞与纤维连接蛋白的黏附。
Oncogene. 2010 Jan 28;29(4):516-26. doi: 10.1038/onc.2009.370. Epub 2009 Nov 23.
4
Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer.厘清过氧化物酶体增殖物激活受体β/δ(PPARβ/δ)在细胞增殖和癌症中的功能作用。
Biochim Biophys Acta. 2009 Dec;1796(2):230-41. doi: 10.1016/j.bbcan.2009.06.002. Epub 2009 Jun 6.
5
A genecentric Human Protein Atlas for expression profiles based on antibodies.基于抗体的、以基因为中心的人类蛋白质图谱用于表达谱分析。
Mol Cell Proteomics. 2008 Oct;7(10):2019-27. doi: 10.1074/mcp.R800013-MCP200.
6
PPAR delta agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycle.过氧化物酶体增殖物激活受体δ激动剂L-165041通过抑制细胞周期来抑制大鼠血管平滑肌细胞的增殖和迁移。
Atherosclerosis. 2009 Feb;202(2):446-54. doi: 10.1016/j.atherosclerosis.2008.05.023. Epub 2008 May 21.
7
Quantitative expression patterns of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) protein in mice.小鼠中过氧化物酶体增殖物激活受体-β/δ(PPARβ/δ)蛋白的定量表达模式
Biochem Biophys Res Commun. 2008 Jul 4;371(3):456-61. doi: 10.1016/j.bbrc.2008.04.086. Epub 2008 Apr 28.
8
RNA interference against peroxisome proliferator-activated receptor delta gene promotes proliferation of human colorectal cancer cells.针对过氧化物酶体增殖物激活受体δ基因的RNA干扰促进人结肠癌细胞增殖。
Dis Colon Rectum. 2008 Mar;51(3):318-26; discussion 326-8. doi: 10.1007/s10350-007-9145-8. Epub 2008 Jan 24.
9
Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.过氧化物酶体增殖物激活受体-β/δ(PPARβ/δ)的配体激活以及环氧合酶2(COX2)的抑制通过独立的信号传导机制减弱结肠癌发生。
Carcinogenesis. 2008 Jan;29(1):169-76. doi: 10.1093/carcin/bgm209. Epub 2007 Sep 24.
10
Molecular mechanisms of the antiproliferative effect of beraprost, a prostacyclin agonist, in murine vascular smooth muscle cells.前列环素激动剂贝拉前列腺素对小鼠血管平滑肌细胞抗增殖作用的分子机制
J Cell Physiol. 2008 Feb;214(2):434-41. doi: 10.1002/jcp.21214.